dpx yb279 vandopløseligt granulat
du pont danmark aps - diflufenican - vandopløseligt granulat - 500 g/kg diflufenican
vydate 10l flydende middel
du pont danmark aps - oxamyl - flydende middel - 100 g/l oxamyl
tanos vanddispergerbart granulat
du pont danmark aps - famoxadon, cymoxanil - vanddispergerbart granulat - 250 g/l famoxadon; 250 g/l cymoxanil
cruiser osr flydende bejdse
syngenta nordics a/s - fludioxonil, thiamethoxam, metalaxyl-m - flydende bejdse - 8 g/l fludioxonil ; 280 g/l thiamethoxam ; 33,3 g/l metalaxyl-m
vibrance duo flydende bejdse
syngenta nordics a/s - fludioxonil, sedaxan - flydende bejdse - 25 g/l fludioxonil; 25 g/l sedaxane
vibrance gold flydende bejdse
syngenta nordics a/s - difenoconazol, fludioxonil, sedaxan - flydende bejdse - 25 g/l difenoconazol; 25 g/l fludioxonil; 50 g/l sedaxane
vibrance star flydende middel
syngenta nordics a/s - fludioxonil, triticonazol, sedaxan - flydende middel - 25 g/l fludioxonil; 20 g/l triticonazol; 25 g/l sedaxane
plexeo 90 emulsionskoncentrat
globachem nv - metconazol - emulsionskoncentrat - 90 g/l metconazol
prialt
esteve pharmaceuticals gmbh - ziconotid - injections, spinal; pain - analgetika - ziconotid er indiceret til behandling af alvorlig kronisk smerte hos patienter, som har brug for intratekal (it) analgesi.
thiotepa riemser
esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.